Serum Proteins Associated with Blood-Brain Barrier as Potential Biomarkers for Seizure Prediction.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Nov 2022
Historique:
received: 15 09 2022
revised: 20 11 2022
accepted: 21 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

As 30% of epileptic patients remain drug-resistant, seizure prediction is vital. Induction of epileptic seizure is a complex process that can depend on factors such as intrinsic neuronal excitability, changes in extracellular ion concentration, glial cell activity, presence of inflammation and activation of the blood−brain barrier (BBB). In this study, we aimed to assess if levels of serum proteins associated with BBB can predict seizures. Serum levels of MMP-9, MMP-2, TIMP-1, TIMP-2, S100B, CCL-2, ICAM-1, P-selectin, and TSP-2 were examined in a group of 49 patients with epilepsy who were seizure-free for a minimum of seven days and measured by ELISA. The examination was repeated after 12 months. An extensive medical history was taken, and patients were subjected to a follow-up, including a detailed history of seizures. Serum levels of MMP-2, MMP-9, TIMP-1, CCL-2, and P-selectin differed between the two time points (p < 0.0001, p < 0.0001, p < 0.0001, p < 0.0001, p = 0.0035, respectively). General linear model analyses determined the predictors of seizures. Levels of MMP-2, MMP-9, and CCL-2 were found to influence seizure count in 1, 3, 6, and 12 months of observation. Serum levels of MMP-2, MMP-9, and CCL-2 may be considered potential biomarkers for seizure prediction and may indicate BBB activation.

Identifiants

pubmed: 36499038
pii: ijms232314712
doi: 10.3390/ijms232314712
pmc: PMC9740683
pii:
doi:

Substances chimiques

Matrix Metalloproteinase 9 EC 3.4.24.35
Matrix Metalloproteinase 2 EC 3.4.24.24
Biomarkers 0
Blood Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Institute of Psychiatry and Neurology
ID : project number 501-15-021-20016 within statutory activity

Références

Cancer Res. 2007 Sep 15;67(18):8615-23
pubmed: 17875701
Acta Neurol Scand. 2014 Dec;130(6):360-7
pubmed: 25209931
Cardiovasc Res. 2008 Jul 1;79(1):150-60
pubmed: 18344519
J Neurotrauma. 2009 Nov;26(11):1935-41
pubmed: 19469687
J Neurosci. 2016 Mar 30;36(13):3777-88
pubmed: 27030762
J Cell Biol. 2007 Aug 13;178(4):687-700
pubmed: 17682049
Exp Cell Res. 2004 Jul 1;297(1):197-211
pubmed: 15194436
J Neuroinflammation. 2009 Dec 24;6:40
pubmed: 20034406
J Neurol Sci. 2016 Aug 15;367:291-7
pubmed: 27423606
Nat Rev Immunol. 2011 Oct 10;11(11):762-74
pubmed: 21984070
Clin Pharmacol Ther. 2001 Mar;69(3):89-95
pubmed: 11240971
J Cell Biol. 1989 Dec;109(6 Pt 1):3063-71
pubmed: 2592414
J Child Neurol. 2018 Jul;33(8):528-533
pubmed: 29724126
Brain. 2015 May;138(Pt 5):1208-22
pubmed: 25765328
J Transl Med. 2015 Dec 01;13:378
pubmed: 26626560
Neurochem Int. 2001 Nov-Dec;39(5-6):401-7
pubmed: 11578775
Glia. 2013 Jan;61(1):71-90
pubmed: 22674585
J Neurosci Res. 2006 Apr;83(5):897-906
pubmed: 16477616
J Interferon Cytokine Res. 2001 Jul;21(7):495-501
pubmed: 11506743
Matrix Biol. 2019 Jan;75-76:102-113
pubmed: 29158162
Prog Neurobiol. 2013 Jun;105:60-78
pubmed: 23567503
Circulation. 1998 Sep 22;98(12):1164-71
pubmed: 9743506
Mol Immunol. 2013 Aug;55(1):100-4
pubmed: 23351392
J Cereb Blood Flow Metab. 2016 Sep;36(9):1481-507
pubmed: 27323783
PLoS One. 2015 Apr 07;10(4):e0122405
pubmed: 25849778
Epilepsia. 2021 Sep;62(9):2159-2170
pubmed: 34250596
Crit Rev Biochem Mol Biol. 2002 Dec;37(6):375-536
pubmed: 12540195
J Child Neurol. 2018 Dec;33(14):909-917
pubmed: 30303442
Brain Dev. 2010 Oct;32(9):695-702
pubmed: 19954907
Mol Med. 2007 Jan-Feb;13(1-2):1-13
pubmed: 17515952
Eur J Neurol. 2016 Jul;23(7):1218-27
pubmed: 27105632
Arch Endocrinol Metab. 2018 Apr 05;62(2):212-220
pubmed: 29641741
Sci Rep. 2022 May 3;12(1):7138
pubmed: 35504954
Immunol Rev. 2012 Jul;248(1):228-39
pubmed: 22725965
Lancet Neurol. 2017 Jul;16(7):523-531
pubmed: 28483337
Epilepsia. 2012 Nov;53(11):1887-97
pubmed: 22984896
Nat Med. 2008 Dec;14(12):1377-83
pubmed: 19029985
Glia. 2010 Feb;58(3):344-66
pubmed: 19780201
Arq Neuropsiquiatr. 2015 Dec;73(12):1014-8
pubmed: 26677122
J Exp Med. 2006 Apr 17;203(4):1007-19
pubmed: 16585265
Hippocampus. 2010 Oct;20(10):1105-8
pubmed: 20043284
J Neurosci. 2008 Oct 22;28(43):10928-36
pubmed: 18945900
J Neuroimmunol. 2014 Jun 15;271(1-2):36-42
pubmed: 24746448
Epilepsy Res. 2016 May;122:114-9
pubmed: 27016865
Brain Behav Immun. 2008 Aug;22(6):797-803
pubmed: 18495419
Am J Physiol Renal Physiol. 2008 Sep;295(3):F749-57
pubmed: 18579703
Am J Physiol. 1994 Oct;267(4 Pt 1):C1112-8
pubmed: 7943274
Epilepsia. 2010 Sep;51(9):1763-73
pubmed: 20345941
Turk Neurosurg. 2021;31(2):228-232
pubmed: 33372257
Genes Dev. 2000 Jan 15;14(2):163-76
pubmed: 10652271
Proc Natl Acad Sci U S A. 1985 Oct;82(20):7136-9
pubmed: 3863143
Cell Rep. 2015 Feb 24;10(7):1040-54
pubmed: 25704809
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20262-7
pubmed: 18077379
Epilepsia. 1996 Nov;37(11):1043-50
pubmed: 8917053
Turk Neurosurg. 2015;25(5):749-56
pubmed: 26442541
Stroke. 2007 Jan;38(1):162-9
pubmed: 17122420
Front Cell Neurosci. 2014 Aug 14;8:234
pubmed: 25177271
Epilepsy Res. 2013 Mar;104(1-2):45-58
pubmed: 23182966
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
J Leukoc Biol. 2007 Dec;82(6):1375-81
pubmed: 17709402
J Comp Neurol. 2001 Jun 11;434(4):461-77
pubmed: 11343293
J Neurochem. 2016 Oct;139 Suppl 2:91-114
pubmed: 26525923
Clin Chim Acta. 2004 Apr;342(1-2):1-12
pubmed: 15026262
Seizure. 2013 Mar;22(2):99-102
pubmed: 23146618
Neurosci Lett. 2010 Oct 29;484(2):139-42
pubmed: 20727940
J Neurosci Res. 2007 Oct;85(13):2813-23
pubmed: 17387691
Brain Behav Immun. 2011 Jun;25 Suppl 1:S106-19
pubmed: 21356306
Epilepsy Res. 2017 Jan;129:33-36
pubmed: 27886560
Front Cell Neurosci. 2018 Feb 19;12:40
pubmed: 29515373
Sci Signal. 2008 Jul 08;1(27):re6
pubmed: 18612141
Oxid Med Cell Longev. 2015;2015:120641
pubmed: 26290681
Epilepsia. 2010 Apr;51(4):676-85
pubmed: 20196795
J Cell Biol. 2008 Mar 10;180(5):1021-35
pubmed: 18332222
Epilepsy Res. 2020 May;162:106301
pubmed: 32126476
Epilepsia. 2007;48 Suppl 5:53-64
pubmed: 17910582
Trends Ecol Evol. 2009 Mar;24(3):127-35
pubmed: 19185386
J Immunol. 1998 Dec 15;161(12):6896-903
pubmed: 9862722
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):4037-42
pubmed: 11891290
J Clin Invest. 2017 Jun 1;127(6):2118-2132
pubmed: 28504645
Brain. 2007 Feb;130(Pt 2):521-34
pubmed: 17124188
J Neurochem. 2006 Mar;96(5):1227-41
pubmed: 16464240
J Cereb Blood Flow Metab. 2007 Apr;27(4):697-709
pubmed: 16850029
Epilepsia. 2010 Jun;51(6):1069-77
pubmed: 19889013
Am J Pathol. 2011 Aug;179(2):860-8
pubmed: 21704005
J Biol Chem. 2000 Aug 25;275(34):26411-5
pubmed: 10827175
Microsc Res Tech. 2003 Apr 15;60(6):540-51
pubmed: 12645002
J Biomed Sci. 2015 Jun 24;22:46
pubmed: 26100815
PLoS One. 2012;7(5):e35919
pubmed: 22586454
Exp Neurol. 2002 Nov;178(1):13-20
pubmed: 12460604
Pharmacol Rep. 2009 Jan-Feb;61(1):22-32
pubmed: 19307690
J Neuroinflammation. 2015 Jul 02;12:129
pubmed: 26133170
Immunity. 2012 Aug 24;37(2):290-301
pubmed: 22863835
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Int J Oncol. 2014 May;44(5):1551-60
pubmed: 24603891
J Neurosci. 2001 Oct 1;21(19):7724-32
pubmed: 11567062
Mol Cell Neurosci. 2009 Jan;40(1):98-110
pubmed: 18976709
Epilepsia. 2007 Apr;48(4):732-42
pubmed: 17319915
J Neurosci Res. 1993 Jun 15;35(3):297-304
pubmed: 8350390
J Neurosci. 2009 May 6;29(18):6007-12
pubmed: 19420267
J Neuroinflammation. 2018 May 15;15(1):144
pubmed: 29764485
Mol Cell Biochem. 2019 May;455(1-2):195-206
pubmed: 30564960
Neurology. 1991 Jul;41(7):965-72
pubmed: 2067659
J Neuroimmunol. 2010 Jul 27;224(1-2):93-100
pubmed: 20681057
J Cell Sci. 2003 Nov 15;116(Pt 22):4615-28
pubmed: 14576355
Biol Chem. 2007 Nov;388(11):1227-34
pubmed: 17976016
Blood. 2017 Jul 13;130(2):181-191
pubmed: 28515093
J Immunol Methods. 2008 Jul 20;336(1):78-84
pubmed: 18495149
J Cereb Blood Flow Metab. 2004 Jul;24(7):720-7
pubmed: 15241180
Epilepsia. 1996 Jun;37(6):563-71
pubmed: 8641234

Auteurs

Elżbieta Bronisz (E)

Second Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.

Agnieszka Cudna (A)

Second Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.

Aleksandra Wierzbicka (A)

Sleep Disorders Center, Department of Clinical Neurophysiology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.

Iwona Kurkowska-Jastrzębska (I)

Second Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH